OCX News and Press, Oncocyte Corporation From 05/15/24

Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...

2024-05-14 17:35:45 ET More on OncoCyte OncoCyte Corporation (OCX) Q4 2023 Earnings Call Transcript Oncocyte stock rallies 90% post-market on Bio-Rad partnership Seeking Alpha’s Quant Rating on OncoCyte Historical earnings data for OncoCyte Fin...

2024-05-13 11:32:17 ET More on OncoCyte Oncocyte stock rallies 90% post-market on Bio-Rad partnership Seeking Alpha’s Quant Rating on OncoCyte Historical earnings data for OncoCyte Financial information for OncoCyte Read the full article on S...

IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that the company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, after U.S. market close. The company will host a conferen...

NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView announces the release of an insightful interview with Oncocyte Corporation’s Chief Executive Officer, Josh Riggs, as the company works to disrupt the mature diagnostics marketplace with a nimble, capital-light approach to ...

2024-04-15 08:21:07 ET More on Pre-market losers & stocks. OncoCyte Corporation (OCX) Q4 2023 Earnings Call Transcript Monogram Orthopaedics, Inc. (MGRM) Q4 2023 Earnings Call Transcript Monogram Orthopaedics, Inc. 2023 Q4 - Results - Earnings Call Presentation ...

2024-04-12 13:44:09 ET OncoCyte Corporation (OCX) Q4 2023 Results Conference Call April 12, 2024 8:00 AM ET Company Participants Jeff Ramson - PCG Advisory Josh Riggs - President, CEO Conference Call Participants Mike Matson - Needham Mason Carrico - ...

2024-04-12 06:32:33 ET More on Oncocyte Oncocyte stock rallies 90% post-market on Bio-Rad partnership Seeking Alpha’s Quant Rating on OncoCyte Historical earnings data for OncoCyte Financial information for OncoCyte Read the full article on S...

IRVINE, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the year ended December 31, 2023. Recent Highlights Bio-Rad Laboratories, Inc. commercial partnership for transplant...

2024-04-12 04:10:54 ET More on OncoCyte Oncocyte stock rallies 90% post-market on Bio-Rad partnership Seeking Alpha’s Quant Rating on OncoCyte Historical earnings data for OncoCyte Financial information for OncoCyte Read the full article on S...